Navigating and communicating about serious illness and end of life

VA Jackson, L Emanuel - New England Journal of Medicine, 2024 - Mass Medical Soc
Key Clinical Points Navigating and Communicating about Serious Illness and End of Life
Partnering with patients as they navigate serious illness requires effectively communicating …

Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial

A El-Jawahri, TW LeBlanc, A Kavanaugh… - JAMA …, 2021 - jamanetwork.com
Importance Patients with acute myeloid leukemia (AML) receiving intensive chemotherapy
experience substantial decline in their quality of life (QOL) and mood during their …

Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care

U Wedding - The Lancet Healthy Longevity, 2021 - thelancet.com
Palliative care, hospice care, and end of life care have been the focus of increased attention
over the past two decades; palliative care has shifted from being introduced only at the end …

Psychological mobile app for patients with acute myeloid leukemia: a pilot randomized clinical trial

A El‐Jawahri, MR Luskin, JA Greer, L Traeger… - Cancer, 2023 - Wiley Online Library
Background Patients with acute myeloid leukemia (AML) experience a substantial decline in
quality of life (QoL) and mood during their hospitalization for intensive chemotherapy, yet …

A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: recommendations for service development and implications for palliative care …

CL Stenson, J Vidrine, F Dewhurst… - Palliative …, 2023 - journals.sagepub.com
Background: Chimeric Antigen-Receptor-T-cell (CAR-T) therapy is a potentially life-saving
treatment for refractory haematological malignancies. Internationally, CAR-T services are …

Development of a prognostic awareness impact scale for patients with advanced cancer

K Brenner, JA Greer, V Jackson, E Park… - Journal of Palliative …, 2022 - liebertpub.com
Background: No reliable instruments exist to measure prognostic awareness and its
psychological and behavioral impacts for patients with advanced cancer. Methods: We …

The experience of patients with hematological malignancy in their terminal stage: a phenomenological study from Jordan's perspective

MM Alnaeem, A Shehadeh, AJ Nashwan - BMC Palliative Care, 2024 - Springer
Background Patients diagnosed with hematological malignancies residing in low-middle-
income countries undergo significant physical and psychological stressors. Despite this …

Advancing palliative care integration in hematology: building upon existing evidence

GA Robbins-Welty, JA Webb, D Shalev… - … treatment options in …, 2023 - Springer
Opinion statement Patients with hematologic malignancies and their families are among the
most distressed of all those with cancer. Despite high palliative care-related needs, the …

Thermoresponsive Polypeptide Fused L‐Asparaginase with Mitigated Immunogenicity and Enhanced Efficacy in Treating Hematologic Malignancies

S Zhang, Y Sun, L Zhang, F Zhang, W Gao - Advanced Science, 2023 - Wiley Online Library
L‐Asparaginase (ASP) is well‐known for its excellent efficacy in treating hematological
malignancies. Unfortunately, the intrinsic shortcomings of ASP, namely high …

Differential impact of a Multicomponent goals-of-care program in patients with hematologic and solid malignancies

D Hui, S Ahmed, N Nortje, M George, CR Andersen… - Cancers, 2023 - mdpi.com
Simple Summary Goals-of-care discussions can help patients to understand their illness and
to share their values and treatment preferences with their clinicians. Here, we compared the …